Supplementary Table from &lt;i&gt;PIK3CA&lt;/i&gt; and &lt;i&gt;AKT1&lt;/i&gt; Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System